The impact of modifiable family factors on glycemic control among youth with type 1 diabetes

Pediatric Diabetes

Volumn 9, Issue 4 PART 2, 2008, Pages 373-381

  Butler, Deborah A ^a,b   Zuehlke, Jessica B ^a,b,d   Tovar, Alison ^a,b,e   Volkening, Lisa K ^a,b   Anderson, Barbara J ^c   Laffel, Lori M B ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF HARTFORD   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Family; Knowledge; Psychosocial factors; T1DM; Youth

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADOLESCENT DEVELOPMENT; AFFECT; AGE; ARTICLE; ATTITUDE TO ILLNESS; BIVARIATE ANALYSIS; BLOOD GLUCOSE MONITORING; CAREGIVER BURDEN; CHILD BEHAVIOR; CHILD CARE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; PARENT COUNSELING; PARENTAL BEHAVIOR; PATIENT CARE; PHYSICAL DEVELOPMENT; PREDICTION; PRIORITY JOURNAL; SCHOOL CHILD; SOCIAL STATUS;

ADOLESCENT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PATIENT COMPLIANCE; RISK FACTORS;

EID: 48649106257     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00370.x     Document Type: Article

References (39)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
2. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994: 125: 177-188.
3. White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001: 139: 804-812.
4. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999: 22: 99-111.
5. Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005: 353: 2643-2653.
6. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986: 315: 215-219.
7. Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 2002: 18: 192-200.
8. Moran A, Jacobs DR Jr, Steinberger J et al. Insulin resistance during puberty: Results from clamp studies in 357 children. Diabetes 1999: 48: 2039-2044.
9. Carnegie Council on Adolescent Development. Great Transitions: Preparing Adolescents for a New Century. New York: Carnegie Corporation of New York, 1995.
10. Anderson BJ, Brackett J, Ho J, Laffel LM. An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control. Diabetes Care 1999: 22: 713-721.
11. Rosilio M, Cotton JB, Wieliczko MC et al. Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group. Diabetes Care 1998: 21: 1146-1153.
12. Anderson BJ, Vangsness L, Connell A, Butler D, Goebel-Fabbri A, Laffel LM. Family conflict, adherence, and glycaemic control in youth with short duration type 1 diabetes. Diabet Med 2002: 19: 635-642.
13. Moreland EC, Tovar A, Zuehlke JB, Butler DA, Milaszewski K, Laffel LM. The impact of physiological, therapeutic and psychosocial variables on glycemic control in youth with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004: 17: 1533-1544.
14. Scottish Study Group for the Care of the Young Diabetic. Factors influencing glycemic control in young people with type 1 diabetes in Scotland: A population-based study (DIABAUD2). Diabetes Care 2001: 24: 239-244.
15. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003: 27 (Suppl. 2): S18-S20.
16. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 2007: 8: 408-418.
17. National Institute for Clinical Excellence (NICE). CG15 Type 1 Diabetes: Diagnosis and Management of Type 1 Diabetes in Children, Young People and Adults - NICE Guideline. National Institute for Clinical Excellence, London. 2005.
18. American Diabetes Association. Standards of medical care in diabetes - 2007. Diabetes Care 2007: 30 (Suppl. 1): S4-S41.
19. Silverstein J, Klingensmith G, Copeland K et al. Care of children and adolescents with type 1 diabetes: A statement of the American Diabetes Association. Diabetes Care 2005: 28: 186-212.
20. Anderson BJ, Ho J, Brackett J, Finkelstein D, Laffel L. Parental involvement in diabetes management tasks: Relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr 1997: 130: 257-265.
21. Butler DA, Volk HE, Loughlin CA, Anderson BJ, Laffel LMB. Importance of family involvement for youth with type 1 diabetes receiving insulin pump therapy (Abstract). Diabetes 2002: 51 (Suppl. 2): A17.
22. Laffel LM, Vangsness L, Connell A, Goebel-Fabbri A, Butler D, Anderson BJ. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr 2003: 142: 409-416.
23. Wysocki T, Taylor A, Hough BS, Linscheid TR, Yeates KO, Naglieri JA. Deviation from developmentally appropriate self-care autonomy. Association with diabetes outcomes. Diabetes Care 1996: 19: 119-125.
24. Hollingshead AB. Four Factor Index of Social Status. New Haven: Yale University, 1975.
25. Johnson PD, Burkhart NT, Anderson B, White N, Funnell M, Barr P. Teenagers with Type 1 Diabetes: A Curriculum for Adolescents and Families. Alexandria: American Diabetes Association, 2000.
26. Hood KK, Butler DA, Volkening LK, Anderson BJ, Laffel LM. The blood glucose monitoring communication questionnaire: An instrument to measure affect specific to blood glucose monitoring. Diabetes Care 2004: 27: 2610-2615.
27. Antisdel JE. Diabetes-specific distress among parents of youth with type 1 diabetes (Abstract). Diss Abst Int 2001: 61: 6123.
28. Polonsky WH, Anderson BJ, Lohrer PA et al. Assessment of diabetes-related distress. Diabetes Care 1995: 18: 754-760.
29. Tamborlane WV, Bonfig W, Boland E. Recent advances in treatment of youth with type 1 diabetes: Better care through technology. Diabet Med 2001: 18: 864-870.
30. Wood JR, Moreland EC, Volkening LK, Svoren BM, Butler DA, Laffel LM. Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care 2006: 29: 2355-2360.
31. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004: 27: 1554-1558.
32. Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005: 28: 1277-1281.
33. Di Meglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004: 145: 380-384.
34. Nabhan ZM, Rardin L, Meier J, Eugster EA, Di Meglio LA. Predictors of glycemic control on insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 2006: 74: 217-221.
35. Svoren BM, Volkening LK, Butler DA, Moreland EC, Anderson BJ, Laffel LMB. Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes. J Pediatr 2007: 150: 279-285.
36. Alemzadeh R, Palma-Sisto P, Parton E, Totka J, Kirby M. Beneficial effects of flexible insulin therapy in children and adolescents with type 1 diabetes mellitus. Acta Diabetol 2003: 40: 137-142.
37. Weintrob N, Benzaquen H, Galatzer A et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial. Pediatrics 2003: 112: 559-564.
38. Levine BS, Anderson BJ, Butler DA, Brackett J, Laffel L. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 2001: 139: 197-203.
39. Hood KK, Butler DA, Anderson BJ, Laffel LMB. Updated and revised Diabetes Family Conflict Scale. Diabetes Care 2007: 30: 1764-1769.